carbachol has been researched along with Acute Myelogenous Leukemia in 1 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Peracchi, M | 1 |
| Maiolo, AT | 1 |
| Lombardi, L | 1 |
| Catena, FB | 1 |
| Polli, EE | 1 |
1 other study available for carbachol and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Patterns of cyclic nucleotides in normal and leukaemic human leucocytes.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Carbachol; Cyclic AMP; Cyclic GMP; Guanylate | 1980 |